can semaglutide affect your liver Why are GLP-1 agonists being used to treat patients with Understanding Semaglutide: A Key to

Description

It may not be recommended for individuals with a history of medullary thyroid cancer, pancreatitis, or certain endocrine conditions

Future of clinical trials once therapies are approved With multiple agents currently in phase III clinical trials, it is important to consider how the eventual approval of a pharmacologic agent for NASH will impact ongoing and future clinical trials in this arena

Keeping a short food and symptom log can make patterns easier to see

You should never start semaglutide, tirzepatide, or any other GLP-1 receptor agonist without a complete medical evaluation, comprehensive blood work, and a clear treatment plan from a qualified provider who understands the nuances of these medications and how to monitor them over time